Monday, April 27, 2009

Blue Lobbying Goes Green: Podesta Group Grows Revenues 45%

From 2007 to 2008 The Podesta Group's lobbying income grew from $11 million to nearly $16 million. Ten pharmaceutical/biotech companies paid Podesta over $2.2 million in 2008. Three for-profit health care groups forked over $940,000 for lobbying services.

One of those firms, DaVita, had Nancy-Ann DeParle on their board of directors. Nancy-Ann is the White House Health Czar, fresh off a long stint in private equity. She served on eight for-profit health care corporate boards.

The Blue team corporafornicates almost as well as the Reds. Watch health care reform closely. The for-profit side is pouring money into our governmental sinkhole on the Potomac. Today's Washington Post did its part by framing the desire to have a public plan as part of health care reform "bizarre and counterproductive." How is it bizarre and counterproductive to want a non-greed inspired group to insure Americans? WellPoint once predicted 15% annual returns as far as the eye could see.

Set aside the Washington Post's obvious framing. WaPo paid Podesta Group $80.000 for lobbying services in 2008. It's a small world after all.

No comments: